A promising research on cancer treatment will be presented to investors

The technology from MUNI was chosen for Academic Innovators presentation at BIO-Europe Spring 2019. Our researcher Vítězslav Bryja is going to speak about promising research of highly potent and selective inhibitors of CK1 kinases for the treatment of leukemias, lymphomas and solid tumors. TTO MUNI is looking for a research partner and a licensee for this technology.